-
Mashup Score: 0Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Retrospective data hint at antitumor activity, but other explanations are possible
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Province‐Wide Analysis of Patient‐Reported Outcomes for Stage IV Non‐Small Cell Lung Cancer - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Pan‐cancer analysis of prognostic metastatic phenotypes - 3 year(s) ago
Metastatic cancer is typically fatal, but survival can range from weeks to years. Currently, however, there is only one category of stage IV cancer; thus, prognostication is unreliable. To better ref…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Breast Cancer‐Specific Mortality in Small‐Sized Tumor with Stage IV Breast Cancer: A Population‐Based Study - 3 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2The secret signals tumor cell clusters use to drive metastasis - 4 year(s) ago
Fred Hutch metastatic breast cancer researcher Dr. Kevin Cheung and his team have discovered secret spaces between the cells of microscopic tumor cell clusters where the signal to grow is co-opted and miscommunicated to other cells. They’re now working on new ways to block that signal — call it growth factor “fake news” — in order to stop metastasis in its tracks.
Source: Fred HutchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Overall Survival with #Brentuximab #Vedotin in Stage III or IV #HodgkinsLymphoma "Patients who received A+AVD... had a survival advantage over those who received ABVD"👇 https://t.co/uQyZeVrvNf @DrDavidStraus @KLFenton #StageIII #StageIV https://t.co/habp71d9UI